Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
- Products
-
- Duloxetine Delayed-Release Capsules USP
- Company
- Rising Pharma Holding, Inc.
- Where it was sold
-
Nationwide.
Nationwide
- Units affected
- 209,376 bottles
- About this recall
- Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ NDC 57237-017-60